Eur Rev Med Pharmacol Sci 2024; 28 (1): 402-410
DOI: 10.26355/eurrev_202401_34929

Meta-analysis of risk factors for restenosis after stent implantation in patients with ischemic cerebrovascular disease

Z.-Y. Peng, Y.-H. Ji, Y. Li, F. Wang

Department of Neurosurgery, Affiliated Hospital of Weifang Medical College, Weifang, China. 18122201195@163.com


OBJECTIVE: The aim of this study was to investigate the risk factors for restenosis after stent implantation in patients with ischemic cerebrovascular disease (ICVD), and to provide a reference for potential measures to prevent ICVD.

MATERIALS AND METHODS: Relevant studies were identified by searching PubMed, ScienceDirect and Web of Science databases. Combined adjusted odds ratios and 95% confidence intervals were calculated.

RESULTS: Seven case-control studies were identified in the end. Diabetes mellitus and residual stenosis were the two main risk factors for restenosis (OR = 0.59, 95% CI: 0.39-0.91, p = 0.01; OR = 36.73, 95% CI: 19.72-70.02, p < 0.001). Gender, smoking, hypertension, dyslipidemia, and stent type were not significantly associated with restenosis (OR = 0.85, 95% CI: 0.53-1.38, p = 0.52; OR = 1.30, 95% CI: 0.91-1.86, p = 0.15; OR = 0.86, 95% CI: 0.16-4.66, p = 0.86; OR = 1.30, 95% CI: 0.58-2.91, p = 0.53; OR = 1.34, 95% CI: 0.72-2.48, p = 0.35).

CONCLUSIONS: The prevention of restenosis after stenting is particularly important for ICVD patients with diabetes or a high residual stenosis rate.

Free PDF Download

To cite this article

Z.-Y. Peng, Y.-H. Ji, Y. Li, F. Wang
Meta-analysis of risk factors for restenosis after stent implantation in patients with ischemic cerebrovascular disease

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 1
Pages: 402-410
DOI: 10.26355/eurrev_202401_34929